Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation

References

• Alzubaidi AF, El-Helw AM, Ahmed TA, Ahmed OA. 2017. The use of experimental design in the optimization of risperidone biodegradable nanoparticles: in vitro and in vivo study. Artif Cells Nanomed Biotechnol. 45:313–320.
   PubMed Web of Science ®Google Scholar
• Amasya G, Badilli U, Aksu B, Tarimci N. 2016. Quality by design case study 1: design of 5-fluorouracil loaded lipid nanoparticles by the W/O/W double emulsion – solvent evaporation method. Eur J Pharm Sci. 84:92–102.
   PubMed Web of Science ®Google Scholar
• Asghar S, Salmani JM, Hassan W, Xie Y, Meng F, Su Z, Sun M, Xiao Y, Ping Q. 2014. A facile approach for crosslinker free nano self assembly of protein for anti-tumor drug delivery: factors’ optimization, characterization and in vitro evaluation. Eur J Pharm Sci. 63:53–62. eng.
   PubMed Web of Science ®Google Scholar
• Bahari Javan N, Shirmard LR, Jafary Omid N, Akbari Javar H, Rafiee Tehrani M, Abedin Dorkoosh F. 2016. Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide. J Microencapsul. 33:460–474.
   PubMed Web of Science ®Google Scholar
• Baş D, Boyacı İH. 2007. Modeling and optimization I: usability of response surface methodology. J Food Eng. 78:836–845.
   Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. 2005. Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol. J Microencapsul. 22:773–785.
   PubMed Web of Science ®Google Scholar
• Cao X, Shoichet MS. 1999. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials. 20:329–339.
   PubMed Web of Science ®Google Scholar
• Chaubey P, Patel RR, Mishra B. 2014. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis. Expert Opinion Drug Deliv. 11:1163–1181.
   PubMed Web of Science ®Google Scholar
• Chiellini EE, Chiellini F, Solaro R. 2006. Bioerodible polymeric nanoparticles for targeted delivery of proteic drugs. J Nanosci Nanotechnol. 6:3040–3047.
   PubMed Web of Science ®Google Scholar
• Coppi G, Iannuccelli V, Leo E, Bernabei MT, Cameroni R. 2002. Protein immobilization in crosslinked alginate microparticles. J Microencapsul. 19:37–44.
   PubMed Web of Science ®Google Scholar
• Crotts G, Sah H, Park TG. 1997. Adsorption determines in-vitro protein release rate from biodegradable microspheres: quantitative analysis of surface area during degradation. J Control Release. 47:101–111.
   Web of Science ®Google Scholar
• Ding J, He R, Zhou G, Tang C, Yin C. 2012. Multilayered mucoadhesive hydrogel films based on thiolated hyaluronic acid and polyvinylalcohol for insulin delivery. Acta Biomater. 8:3643–3651.
   PubMed Web of Science ®Google Scholar
• El-Leithy ES, Shaker DS, Ghorab MK, Abdel-Rashid RS. 2010. Optimization and characterization of diclofenac sodium microspheres prepared by a modified coacervation method. Drug Discov Ther. 4:208–216. eng.
   PubMedGoogle Scholar
• Gaignaux A, Réeff J, Siepmann F, Siepmann J, De Vriese C, Goole J, Amighi K. 2012. Development and evaluation of sustained-release clonidine-loaded PLGA microparticles. Int J Pharm. 437:20–28.
   PubMed Web of Science ®Google Scholar
• Gajra B, Dalwadi C, Patel R. 2015. Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (lipomer) using Box–Behnken design. Daru J Pharm Sci. 23:3.
   Web of Science ®Google Scholar
• Gannu R, Yamsani VV, Yamsani SK, Palem CR, Yamsani MR. 2009. Optimization of hydrogels for transdermal delivery of lisinopril by Box–Behnken Statistical Design. AAPS PharmSciTech. 10:505–514.
   PubMed Web of Science ®Google Scholar
• Gu B, Linehan B, Tseng Y-C. 2015. Optimization of the Büchi B-90 spray drying process using central composite design for preparation of solid dispersions. Int J Pharm. 491:208–217.
   PubMed Web of Science ®Google Scholar
• Haggag Y, Abdel-Wahab Y, Ojo O, Osman M, El-Gizawy S, El-Tanani M, Faheem A, McCarron P. 2016. Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG. Int J Pharm. 499:236–246.
   PubMed Web of Science ®Google Scholar
• He J-T, Su H-B, Li G-P, Tao X-M, Mo W, Song H-Y. 2006. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres. Int J Pharm. 309:101–108.
   PubMed Web of Science ®Google Scholar
• Ismail M-A-M, Mateos L, Maioli S, Merino-Serrais P, Ali Z, Lodeiro M, Westman E, Leitersdorf E, Gulyás B, Olof-Wahlund L, et al. 2017. 27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP/GLUT4 system dysregulation. J Experiment Med. 214:699–717.
   PubMed Web of Science ®Google Scholar
• Iwasa S, Enomoto A, Onoue S, Nakai M, Yajima T, Fukushima T. 2009. Chromatographic analysis of conformationally changed insulin and its cytotoxic effect on PC12 cells. J Health Sci. 55:825–831.
   Google Scholar
• Jiang G, Woo BH, Kang F, Singh J, DeLuca PP. 2002. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres. J Control Release. 79:137–145. eng.
   PubMed Web of Science ®Google Scholar
• Kerbel R, Folkman J. 2002. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer. 2:727–739. eng.
   PubMed Web of Science ®Google Scholar
• Kim HK, Park TG. 1999. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. Biotechnol Bioeng. 65:659–667.
   PubMed Web of Science ®Google Scholar
• Kumar A, Ahuja M. 2013. Carboxymethyl gum kondagogu-chitosan polyelectrolyte complex nanoparticles: preparation and characterization. Int J Biol Macromol. 62:80–84.
   PubMed Web of Science ®Google Scholar
• Lao LL, Peppas NA, Boey FYC, Venkatraman SS. 2011. Modeling of drug release from bulk-degrading polymers. Int J Pharm. 418:28–41.
   PubMed Web of Science ®Google Scholar
• Lu X, Gao H, Li C, Yang Y-W, Wang Y, Fan Y, Wu G, Ma J. 2012. Polyelectrolyte complex nanoparticles of amino poly(glycerol methacrylate)s and insulin. Int J Pharm. 423:195–201.
   PubMed Web of Science ®Google Scholar
• Luo J, Cao S, Chen X, Liu S, Tan H, Wu W, Li J. 2012. Super long-term glycemic control in diabetic rats by glucose-sensitive LbL films constructed of supramolecular insulin assembly. Biomaterials. 33:8733–8742.
   PubMed Web of Science ®Google Scholar
• Mahboubian AHS, Moghadam S, Atyabi F, Dinarvand R. 2010. Preparation and in-vitro evaluation of controlled release PLGA microparticles containing triptoreline. Iran J Pharm Res. 9:369–378.
   PubMed Web of Science ®Google Scholar
• Mahjub R, Dorkoosh FA, Amini M, Khoshayand MR, Rafiee-Tehrani M. 2011. Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan. AAPS PharmSciTech. 12:1407–1419.
   PubMed Web of Science ®Google Scholar
• Manoharan C, Singh J. 2009. Insulin loaded PLGA microspheres: effect of zinc salts on encapsulation, release, and stability. J Pharm Sci. 98:529–542.
   PubMed Web of Science ®Google Scholar
• Marucci M, Ragnarsson G, Nyman U, Axelsson A. 2008. Mechanistic model for drug release during the lag phase from pellets coated with a semi-permeable membrane. J Control Release. 127:31–40.
   PubMed Web of Science ®Google Scholar
• Masood F, Chen P, Yasin T, Fatima N, Hasan F, Hameed A. 2013. Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application. Mater Sci Eng C Mater Biol Appl. 33(3):1054–1060.
   Google Scholar
• McCarthy AA. 2004. New approaches to diabetes disease control, insulin delivery, and monitoring. Chem Biol. 11:1597–1598.
   PubMedGoogle Scholar
• Mirzaei B, Abdi H, Serahati S, Barzin M, Niroomand M, Azizi F, Hosseinpanah F. 2017. Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study. Atherosclerosis. 258:65–71.
   PubMed Web of Science ®Google Scholar
• Molina SA, Moriarty HK, Infield DT, Imhoff BR, Vance RJ, Kim AH, Hansen JM, Hunt WR, Koval M, McCarty NA. 2017. Insulin signaling via the PI3-kinase/Akt pathway regulates airway glucose uptake and barrier function in a CFTR-dependent manner. Am J Physiol. 312:L688–L702.
   Google Scholar
• Mortazavian E, Amini M, Dorkoosh FA, Amini H, Khoshayand MR, Amini T, Rafiee-Tehrani M. 2014. Preparation, design for optimization and in vitro evaluation of insulin nanoparticles integrating thiolated chitosan derivatives. J Drug Deliv Sci Technol. 24:40–49.
   Web of Science ®Google Scholar
• Nasti A, Zaki NM, de Leonardis P, Ungphaiboon S, Sansongsak P, Rimoli MG, Tirelli N. 2009. Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: systematic optimisation of the preparative process and preliminary biological evaluation. Pharm Res. 26:1918–1930.
   PubMed Web of Science ®Google Scholar
• O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, et al. 2013. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 61:485–510.
   Google Scholar
• Patel RR, Chaurasia S, Khan G, Chaubey P, Kumar N, Mishra B. 2016. Cromolyn sodium encapsulated PLGA nanoparticles: an attempt to improve intestinal permeation. Int J Biol Macromol. 83:249–258.
   PubMed Web of Science ®Google Scholar
• Peng Q, Zhang Z-R, Gong T, Chen G-Q, Sun X. 2012. A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles. Biomaterials. 33:1583–1588.
   PubMed Web of Science ®Google Scholar
• Piejko M, Dec R, Babenko V, Hoang A, Szewczyk M, Mak P, Dzwolak W. 2015. Highly amyloidogenic two-chain peptide fragments are released upon partial digestion of insulin with pepsin. J Biol Chem. 290:5947–5958.
   PubMed Web of Science ®Google Scholar
• Ramazani F, Chen W, Van Nostrum CF, Storm G, Kiessling F, Lammers T, Hennink WE, Kok RJ. 2015. Formulation and characterization of microspheres loaded with imatinib for sustained delivery. Int J Pharm. 482:123–130.
   PubMed Web of Science ®Google Scholar
• Rezaie Shirmard L, Bahari JN, Khoshayand MR, Kebriaee-Zadeh A, Dinarvand R, Dorkoosh FA. 2015. Nanoparticulate fingolimod delivery system based on biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): design, optimization, characterization and in-vitro evaluation. Pharm Dev Technol. 22:860–870.
   PubMed Web of Science ®Google Scholar
• Rizkalla N, Hildgen P. 2005. Artificial neural networks: comparison of two programs for modeling a process of nanoparticle preparation. Drug Dev Indust Pharm. 31:1019–1033.
   PubMed Web of Science ®Google Scholar
• Saadat E, Abdollahi A, Dorkoosh FA. 2015. Fabrication and characterization of risperidone implants as an extended antipsychotic delivery system, exploring the role of excipients. J Pharm Innov. 10:118–129.
   Web of Science ®Google Scholar
• Sahana DK, Mittal G, Bhardwaj V, Kumar MNVR. 2008. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J Pharm Sci. 97:1530–1542.
   PubMed Web of Science ®Google Scholar
• Scheithauer EC, Li W, Ding Y, Harhaus L, Roether JA, Boccaccini AR. 2015. Preparation and characterization of electrosprayed daidzein-loaded PHBV microspheres. Mater Lett. 158:66–69.
   Web of Science ®Google Scholar
• Sepehri N, Rouhani H, Tavassolian F, Montazeri H, Khoshayand MR, Ghahremani MH, Ostad SN, Atyabi F, Dinarvand R. 2014. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan. Int J Pharm. 471:485–497.
   PubMed Web of Science ®Google Scholar
• Shantha Kumar TR, Soppimath K, Nachaegari SK. 2006. Novel delivery technologies for protein and peptide therapeutics. Curr Pharm Biotechnol. 7:261–276.
   PubMed Web of Science ®Google Scholar
• Sheu D-S, Chen W-M, Yang J-Y, Chang R-C. 2009. Thermophilic bacterium Caldimonas taiwanensis produces poly(3-hydroxybutyrate-co-3-hydroxyvalerate) from starch and valerate as carbon sources. Enzyme Microb Technol. 44:289–294.
   Web of Science ®Google Scholar
• Showalter MR, Cajka T, Fiehn O. 2017. Epimetabolites: discovering metabolism beyond building and burning. Curr Opin Chem Biol. 36:70–76.
   PubMed Web of Science ®Google Scholar
• Silva AL, Rosalia RA, Sazak A, Carstens MG, Ossendorp F, Oostendorp J, Jiskoot W. 2013. Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activation. Eur J Pharm Biopharm. 83:338–345.
   PubMed Web of Science ®Google Scholar
• Solanki AB, Parikh JR, Parikh RH. 2007. Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box–Behnken design. AAPS PharmSciTech. 8:43.
   Web of Science ®Google Scholar
• The Emerging Risk Factors Collaboration. 2011. Diabetes mellitus, fasting glucose, and risk of cause-specific death. New Engl J Med. 364:829–841.
   PubMed Web of Science ®Google Scholar
• Vilos C, Morales FA, Solar PA, Herrera NS, Gonzalez-Nilo FD, Aguayo DA, Mendoza HL, Comer J, Bravo ML, Gonzalez PA, et al. 2013. Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells. Biomaterials. 34:4098–4108.
   PubMed Web of Science ®Google Scholar
• Wang F, Song Y-l, Li C-x, Li D-h, Zhang H-p, Ma A-j, Xi X-q, Zhang N, Wang B-g, Wang Y, et al. 2010. Sustained release of insulin-like growth factor-1 from poly(lactide-co-glycolide) microspheres improves osseointegration of dental implants in type 2 diabetic rats. Eur J Pharmacol. 640:226–232.
   PubMed Web of Science ®Google Scholar
• Wee Gan C, Chien S, Feng S-S. 2010. Nanomedicine: enhancement of chemotherapeutical efficacy of docetaxel by using a biodegradable nanoparticle formulation. Curr Pharm Design. 16:2308–2320.
   PubMed Web of Science ®Google Scholar
• Wei LMA. 2015. Thermophysical properties of bacterial poly(3-hydroxybutyrate): characterized by TMA, DSC and TMDSC. J Appl Polym Sci. 132:10244–10254.
   Web of Science ®Google Scholar
• Yan F, Zhang C, Zheng Y, Mei L, Tang L, Song C, Sun H, Huang L. 2010. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomedicine. 6:170–178.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Hashide R, Ishii T, Takahashi S, Sato K, Anzai J-I. 2012. Layer-by-layer films composed of poly(allylamine) and insulin for pH-triggered release of insulin. Colloids Surf B Biointerfaces. 91:274–279.
   PubMed Web of Science ®Google Scholar
• Zhang J, Fan Y, Smith E. 2009. Experimental design for the optimization of lipid nanoparticles. J Pharm Sci. 98:1813–1819.
   PubMed Web of Science ®Google Scholar
• Zhang K, Quan C, Huang H, Taulier N, Wu XY. 2004. On the stability of insulin delivered through a new glucose-responsive polymeric composite membrane. J Pharm Pharmacol. 56:611–620.
   PubMed Web of Science ®Google Scholar